“A Practical Approach to the Occult Epidemic of Primary Aldosteronism” (Hybrid Event)

Richard J. Auchus, MD, PhD
Professor of Translational Medicine
University of Michigan

Dr. Auchus is the James A. Shayman and Andrea S. Kevrick Professor of Translational Medicine in the Departments of Pharmacology and Internal Medicine at the University of Michigan. He also serves as Chief of the Endocrinology Section at the LTC Charles S. Kettles Veterans Affairs Healthcare System. Dr. Auchus and his group are active in a wide range of research projects, including basic biochemical principles and structural biology of steroid biosynthetic enzymes, comprehensive steroid mass spectrometry analysis, and clinical trials and translational investigation in disorders of the pituitary, adrenal, ovaries, and testes that cause hypertension, infertility, and obesity. His clinical interests also focus on pituitary, adrenal, and reproductive diseases that involve disorders of steroid production, and he is particularly interested in the care of adults with genetic disorders of steroid biosynthesis and action. He has authored more than 350 journal articles and 40 book chapters, and he has lectured in a wide range of national and international conferences. He was elected to the Association of American Physicians in 2018 and was chosen to deliver the Lawson Wilkins Lecture for the Pediatric Endocrine Society in 2022. He received the Frontiers in Science & Distinction in Endocrinology Award from the American Association of Clinical Endocrinology in 2023 and was the 2021 recipient of the Outstanding Clinical Investigator Award from the Endocrine Society.

___________________________________________________________________

Join Meeting!

OBJECTIVES:

• Interpret screening, confirmatory, and localization tests for primary aldosteronism
• Identify patients with low renin and non-suppressed aldosterone who will benefit from further evaluation
• Characterize low-renin mineralocorticoid-receptor antagonist responsive hypertension

FACULTY DISCLOSURES:

Dr. Auchus has indicated the following relevant financial relationships with commercial interests:

Commercial Interest/Organization
Quest Diagnostics, Corcept Therapeutics, Xeris Pharmaceuticals,
Crinetics   Pharmaceuticals, Adrenas Therapeutics,
Sparrow Pharmaceuticals, Novo Nordisk,
Neurocrine Biosciences/Diurnal LTD,
Recordati Rare Diseases, H Lundbeck A/S

PLANNING COMMITTEE DISCLOSURE:

Dr. Deshpande has indicated that he has no relevant financial relationships with commercial interests.
Dr. Weiss has indicated the following relevant financial relationships with commercial interests:

Financial Relationship                                          Commercial Interest/Organization
Consultant/Contractor                                           Prizm LLC

All the relevant financial relationships for these individuals have been mitigated.

TARGET AUDIENCE:
Primary care physicians.

ACCREDITATION:
The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION:
The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.